DSP Healthcare Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
DSP Healthcare Fund - Regular Plan - Growth
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹231 Cr | ₹3179 Cr |
| Min Investment | ₹5000 | ₹100 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹100 |
| Launch Date | 08 Nov 2021 | 30 Nov 2018 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 18% |
| Expense Ratio | 2.35 | 1.9 |
| Manager | Rohan Korde | Jay Kothari |
| ISIN Code | INF00XX01BL5 | INF740KA1LD8 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | DSP Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 1 Month | -1.98% | -0.94% |
| 6 Month | -4.22% | 0.06% |
| 1 Year | -10.48% | -6.18% |
| 3 Year | 19.03% | 21.41% |
| 5 Year | - | 15.05% |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 6 Month | -2.86% | 0.39% |
| 1 Year | -2.5% | 5.22% |
| 3 Year | 12.43% | 15.95% |
| 5 Year | - | 16.42% |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 1 Year | 18.94% | 24% |
| 3 Year | 20.21% | 21.3% |
| 5 Year | - | 25.59% |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Standard Deviation | 14.52% | 14.69% |
| Sharp | 0.81% | 1% |
| Beta | 0.89% | 0.79% |
| Alpha | -1.07% | 2.42% |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Name | Rohan Korde | Jay Kothari |
| Total AUM | ₹4626 Cr | ₹0 Cr |
| Funds Managed | 10 | 20 |
| ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Others | 2.71 | 20.18 |
| Large Cap | 48.48 | 21.97 |
| Small Cap | 27.6 | 41.71 |
| Mid Cap | 21.21 | 16.14 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Others | 2.71 | 20.18 |
| Pharmaceuticals & Biotechnology | 69.73 | 66.48 |
| Healthcare Services | 22.3 | 11.11 |
| Industrial Manufacturing | 0.97 | - |
| Insurance | 1.26 | 1.5 |
| Healthcare Equipment & Supplies | 0.91 | 0.24 |
| Fertilizers & Agrochemicals | 1.31 | - |
| Chemicals & Petrochemicals | 0.81 | - |
| Retailing | - | 0.49 |
Top Comparisons
Axis Large & Mid Cap Fund - Regular Plan - Growth
3Y Returns19.97%
Sundaram Large and Midcap Fund Regular Plan - Growth
3Y Returns16.87%
Bandhan Financial Services Fund - Regular (G)
3Y Returns0%
Baroda BNP Paribas Banking and Financial Services Fund - Regular - Growth Option
3Y Returns16.04%
Nippon India Medium to Long Duration Fund - Growth Plan - Growth Option
3Y Returns6.66%
UTI Medium to Long Duration Fund- Regular Plan - Growth
3Y Returns6.82%
Nippon India Nifty Smallcap 250 Index Fund - Regular Plan - Growth Option
3Y Returns19.68%
Nippon India Nifty Midcap 150 Index Fund - Regular Plan - Growth Option
3Y Returns23.11%